Abstract:
A multi-lumen multi-purpose catheter (10) which incorporates optical filaments (33) and an optical coupler (30) for use with an external apparatus for determining the oxygen concentration in the blood of a patient under critical care conditions, as well as incorporating therein a heater coil (55) useable with a second external apparatus for measurement of continuous cardiac output. The catheter (10) also includes a thermistor (54) and at least one injectate port (64) for enabling the user to also conduct thermal dilution readings and obtain intermittent measurements of cardiac output. The combination of a thermal dilution catheter with an SV02 catheter and a continuous cardiac output catheter gives the multipurpose catheter (10) substantial versatility as well as providing the user with a versatile cardiac catheter device which enables him to conduct multiple evaluations of disparate blood-related parameters which require the use of separate apparatuses.
Abstract:
A diagnostic and monitoring device (4) is disclosed to determine functionality of the cardio-circulatory system from a performance diagram. The performance diagram diagnoses myocardial impairment, dysfunctions, critical illness, and physical fitness of a subject from the location of a subject's data point with respect to zones of physiological criticality.
Abstract:
A continuous cardiac output monitor includes a general-purpose monitoring console (32) with local display (34) and communications facilities, and a module (40) removably interfacing with the console (32) to configure the latter for performing continuous cardiac output monitoring. The module (40) includes a switch-mode high efficiency power amplifier (60) for providing electrical heating power at a selected voltage, frequency, and wave form to a heating element (50) of a continuous cardiac output monitoring catheter (16), which catheter (16) at a distal end portion thereof is immersed in the blood flow of a patient (10). The catheter (16) effects a temperature transient in the patient's blood flow by the controlled application of electrical resistance heating utilizing electrical power from the power amplifier (60), and this temperature transient is sensed and used to derive a value for the patient's cardiac output.
Abstract:
A cardiac output probe assembly (10) is disclosed wherein the assembly includes a chest tube (12) which carries a cardiac output probe (14) therein. The chest tube (12) includes a main lumen (40) for draining fluids from the thoracic cavity of the chest and a secondary lumen (18) which carries leads (24) attached to the probe (14). The probe (14) is attached to the pulmonary artery or aorta vessel with detachable tines (52) and/or sutures. The tines (52) are uniquely configured to ensure that good contact between the probe (14) and vessel is maintained. When cardiac output monitoring is complete, a pulling force is applied to the probe leads (24) extending out through a proximal end (18) of the tube (12). The pulling force detaches the tines (52) and sutures, releasing the probe (14) from connection with the vessel. Further withdrawal of the leads (24) through the tube (12) retracts the probe (14) within the tube (12), where it is housed until the tube (12) is removed from the thoracic cavity.
Abstract:
The invention relates to a device to determine effective pulmonary blood flow (PBF) by means of partial CO2 rebreathing. The device is characterized in that it comprises an endotracheal tube whose conduit leading from the patient to the respirator is divided up into two lanes between a controllable three-way valve (4) and a Y-piece; one lane builds a larger dead area (6) for CO2 rebreathing whereby, in order to measure CO2 elimination and end expiratory partial CO2 pressure a CO2 sensor (3) and a respiration flow sensor (1) are provided on the endotracheal tube of the patient. The calculation of effective pulmonary blood flow is provided by a microprocessor/controller (7) which also controls the three-way valve (4) which provides the switching between both lanes.
Abstract translation:用于确定的有效肺血流量(PBF)通过部分CO2再呼吸的装置的布置包含一个气管内导管,其患者的可控三通阀(4)之间的呼吸机的线和Y型件(5)被分成两股,的一条链 较大尺寸的死空间(6)形成用于CO2再呼吸。 CO 2传感器(3)和呼吸流量传感器(1)被设置在气管内插管用于CO 2去除和呼气末CO2分压的测量。 微处理器/控制器用于(7)的有效pulvonalen血液流动,这还提供了用于控制由所述三通阀(4)的两条链之间切换的计算。
Abstract:
A method and apparatus for correcting thermal drift in cardiac output measurements based upon a temperature signal indicative of the change in temperature of blood leaving the heart is disclosed. In a first preferred embodiment of a cardiac output monitoring system (10), the catheter (14) is provided with an electrical resistance heater (22). An electrical current having a sinusoidal waveform with a period of from 30 to 60 seconds is applied to the heater, causing power to be dissipated into the blood within a patient's heart (12). A temperature sensor (24) disposed near a distal end of the catheter produces a signal indicative of the temperature of blood leaving the heart. The temperature signal and the signal corresponding to the electrical power dissipated in the heater (an input signal) are filtered at a frequency omega n corresponding to the frequency of the applied electrical current, i.e., the frequency of the input signal. An output signal indicative of the temperature of the blood leaving the heart corrected for the effects of thermal drift is then calculated. The blood temperature output signal is first split into two equal overlapping time periods. The two signals are then filtered separately to produce two partially independent output signals in the frequency domain. These two frequency domain output signals are then combined into a single corrected frequency domain output signal with the effects of thermal drift removed. The amplitude of the input power, the amplitude of the temperature signal corrected for thermal drift, and their phase difference are then used in calculating cardiac output.
Abstract:
The invention relates to a process for determining the cardiac output by detecting a systolic impedance change in a tissue with at least one first and at least one second measuring electrode, where the first is applied to the skin in the region of an a.c. path through the tissue, in which the second measuring electrode is inserted into a vessel lying substantially opposite the heart in relation to the first electrode and held in a predetermined projection on the first electrode passing through the heart.
Abstract:
Method of determining the stroke volume of the human heart from the pulse-type blood-stream pressure signal derived from the aorta and consisting in each case of a systolic and a diastolic period. Said method comprises calculating the flow q(t) from the pressure p(t) and integrating the flow over the systolic period, the aorta being regarded as a transmission line supplemented with a windkessel compliance and the pressure/volume relationship in the aorta as an arctangent relationship. The pressure represented by the pressure signal - for each stroke prior to the calculation of the flow - is linearised by means of the arctangent relationship, for fixed aorta length, of the aorta pressure/cross section, the values, associated with the final diastolic pressure, of the characteristic impedance of the transmission line and windkessel compliance being adhered to or is used without modification. The characteristic impedance of the transmission line and the windkessel compliance are continuously adapted to the pressure of the windkessel compliance for each stroke concerned. Additionally, to calculate the flow, the flow through the peripheral resistance is added.
Abstract:
A method for the measurement of cardiac output in a patient in which the arterial blood pressure waveform of a patient from a blood pressure monitoring device over a period of time is subjected to various transformations and corrections, including autocorrelation, whereby the pulsatility and heart rate of the patient are obtained. The nominal stroke volume is then calculated from the pulsatility and the nominal caridac output obtained by multiplying the stroke volume by the heart rate.
Abstract:
The present invention measures cardiac power and power increase under stress, thus calculating contractile reserve (CR), the difference between cardiac peak power and cardiac power at rest by connecting a person to an electrocardiograph and determining the pressure-volume loop (PVL) of a patient's heart. While deflating an inflated cuff on the person's arm at a controlled rate, a series of data points from peak systolic to diastolic pressure is obtained, each point consisting of cuff pressure at penetration coupled with the time of its occurrence after the corresponding ORS complex; a curve-fitting procedure is applied to turn said data points into a pressure curve resembling the ascending limb of the aortic pressure wave. The end systolic pressure (ESP) is calculated using the expression ESP = DP + 2/3 (PSP - DP), where DP = diastolic pressure and PSP = peak systolic pressure. The volume at point ESP is calculated by integrating said flow curve throughout the ejection phase of the patient's heart.